4/25
09:19 am
ktra
TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
High
Report
TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
4/9
08:15 pm
ktra
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA
Medium
Report
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA
4/8
11:57 pm
ktra
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, SCX, KTRA
Low
Report
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, SCX, KTRA
4/5
08:41 pm
ktra
Lifshitz Law PLLC Announces Investigations of KTRA, CHX, PIK, and LABP
Low
Report
Lifshitz Law PLLC Announces Investigations of KTRA, CHX, PIK, and LABP
4/5
01:31 pm
ktra
KINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRA
Medium
Report
KINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRA
4/3
01:43 pm
ktra
Shareholder Alert: Ademi LLP investigates whether Kintara Therapeutics, Inc. has obtained a Fair Price in its transaction with TuHURA
Low
Report
Shareholder Alert: Ademi LLP investigates whether Kintara Therapeutics, Inc. has obtained a Fair Price in its transaction with TuHURA
4/3
09:28 am
ktra
KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to Shareholders
High
Report
KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to Shareholders
4/3
07:09 am
ktra
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement [Yahoo! Finance]
High
Report
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement [Yahoo! Finance]
4/3
07:00 am
ktra
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
High
Report
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
4/3
07:00 am
ktra
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
High
Report
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
3/27
09:00 am
ktra
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab
Medium
Report
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab
2/14
04:14 pm
ktra
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update [Yahoo! Finance]
2/14
04:07 pm
ktra
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
Low
Report
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
2/12
09:10 am
ktra
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer [Yahoo! Finance]
High
Report
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer [Yahoo! Finance]
2/12
09:00 am
ktra
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
Medium
Report
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer